2.4.0.6 Html 109 187 1 false 30 0 false 5 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.galectintherapeutics.com/taxonomy/role/DocumentDocumentandEntityInformation Document and Entity Information true false R2.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassified CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 104 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfIncomeAlternative CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 106 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) false false R6.htm 107 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfShareholdersEquityAndOtherComprehensiveIncomeParenthetical CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) false false R7.htm 108 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.galectintherapeutics.com/taxonomy/role/StatementOfCashFlowsIndirect CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 109 - Disclosure - Basis of Presentation Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsBasisOfAccounting Basis of Presentation false false R9.htm 110 - Disclosure - Agreement with PROCAPS S.A. Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock Agreement with PROCAPS S.A. false false R10.htm 111 - Disclosure - Accrued Expenses Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accrued Expenses false false R11.htm 112 - Disclosure - Stock-Based Compensation Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation false false R12.htm 113 - Disclosure - Common Stock Warrants Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Common Stock Warrants false false R13.htm 114 - Disclosure - Common Stock and Warrant Offering and Reverse Split Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsStockWarrantsTextBlock Common Stock and Warrant Offering and Reverse Split false false R14.htm 115 - Disclosure - Fair Value of Financial Instruments Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value of Financial Instruments false false R15.htm 116 - Disclosure - Loss Per Share Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Loss Per Share false false R16.htm 117 - Disclosure - Commitments and Contingencies Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock Commitments and Contingencies false false R17.htm 118 - Disclosure - Accrued Expenses (Tables) Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accrued Expenses (Tables) false false R18.htm 119 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) false false R19.htm 120 - Disclosure - Common Stock Warrants (Tables) Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Common Stock Warrants (Tables) false false R20.htm 121 - Disclosure - Loss Per Share (Tables) Sheet http://www.galectintherapeutics.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Loss Per Share (Tables) false false R21.htm 122 - Disclosure - Basis of Presentation - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureBasisOfPresentationAdditionalInformation Basis of Presentation - Additional Information (Detail) false false R22.htm 123 - Disclosure - Agreement with PROCAPS S.A. - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureAgreementWithPROCAPSSAAdditionalInformation Agreement with PROCAPS S.A. - Additional Information (Detail) false false R23.htm 124 - Disclosure - Accrued Expenses (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses (Detail) false false R24.htm 125 - Disclosure - Stock-Based Compensation Expense Related to Common Stock Options, Restricted Common Stock and Common Stock Warrants (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationExpenseRelatedToCommonStockOptionsRestrictedCommonStockAndCommonStockWarrants Stock-Based Compensation Expense Related to Common Stock Options, Restricted Common Stock and Common Stock Warrants (Detail) false false R25.htm 126 - Disclosure - Summary of Stock Option Activity (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureSummaryOfStockOptionActivity Summary of Stock Option Activity (Detail) false false R26.htm 127 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock-Based Compensation - Additional Information (Detail) false false R27.htm 128 - Disclosure - Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureWeightedAverageAssumptionsUsedToDetermineFairValueOfOptionsGranted Weighted Average Assumptions Used to Determine Fair Value of Options Granted (Detail) false false R28.htm 129 - Disclosure - Summary of Stock Warrant Activity (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureSummaryOfStockWarrantActivity Summary of Stock Warrant Activity (Detail) false false R29.htm 130 - Disclosure - Common Stock Warrants - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureCommonStockWarrantsAdditionalInformation Common Stock Warrants - Additional Information (Detail) false false R30.htm 131 - Disclosure - Common Stock and Warrant Offering and Reverse Split - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureCommonStockAndWarrantOfferingAndReverseSplitAdditionalInformation Common Stock and Warrant Offering and Reverse Split - Additional Information (Detail) false false R31.htm 132 - Disclosure - Dilutive Shares Which Could Exist Pursuant to Exercise of Outstanding Stock Instruments and Which were not Included in Calculation (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureDilutiveSharesWhichCouldExistPursuantToExerciseOfOutstandingStockInstrumentsAndWhichWereNotIncludedInCalculation Dilutive Shares Which Could Exist Pursuant to Exercise of Outstanding Stock Instruments and Which were not Included in Calculation (Detail) false false R32.htm 133 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.galectintherapeutics.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation Commitments and Contingencies - Additional Information (Detail) false false All Reports Book All Reports Element us-gaap_EmployeeRelatedLiabilitiesCurrent had a mix of decimals attribute values: -5 -3. Element us-gaap_ProceedsFromIssuanceOrSaleOfEquity had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensation had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate had a mix of decimals attribute values: 3 4 5. Element us-gaap_StockIssuedDuringPeriodValueNewIssues had a mix of decimals attribute values: -3 0. 'Monetary' elements on report '106 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)' had a mix of different decimal attribute values. 'Monetary' elements on report '108 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS' had a mix of different decimal attribute values. 'Monetary' elements on report '122 - Disclosure - Basis of Presentation - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '131 - Disclosure - Common Stock and Warrant Offering and Reverse Split - Additional Information (Detail)' had a mix of different decimal attribute values. 'Monetary' elements on report '133 - Disclosure - Commitments and Contingencies - Additional Information (Detail)' had a mix of different decimal attribute values. Process Flow-Through: 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 104 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: Removing column 'Mar. 22, 2012' Process Flow-Through: 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: 107 - Statement - CONSOLIDATED STATEMENT OF CHANGES IN REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical) Process Flow-Through: 108 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS galt-20120630.xml galt-20120630.xsd galt-20120630_cal.xml galt-20120630_def.xml galt-20120630_lab.xml galt-20120630_pre.xml true true